Your browser is no longer supported. Please, upgrade your browser.
OBLN Obalon Therapeutics, Inc. weekly Stock Chart
Obalon Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.47 Insider Own4.12% Shs Outstand7.73M Perf Week1.43%
Market Cap6.59M Forward P/E- EPS next Y-0.27 Insider Trans0.00% Shs Float7.43M Perf Month5.48%
Income-18.10M PEG- EPS next Q-0.07 Inst Own20.60% Short Float3.97% Perf Quarter29.68%
Sales2.60M P/S2.53 EPS this Y74.40% Inst Trans-19.75% Short Ratio0.96 Perf Half Y27.08%
Book/sh0.93 P/B0.98 EPS next Y80.00% ROA-92.50% Target Price- Perf Year-52.84%
Cash/sh- P/C- EPS next 5Y- ROE-133.40% 52W Range0.62 - 2.24 Perf YTD-51.84%
Dividend- P/FCF- EPS past 5Y4.10% ROI-147.00% 52W High-59.15% Beta-0.81
Dividend %- Quick Ratio1.90 Sales past 5Y-1.50% Gross Margin23.10% 52W Low47.58% ATR0.09
Employees34 Current Ratio1.90 Sales Q/Q75.00% Oper. Margin- RSI (14)60.33 Volatility11.44% 10.13%
OptionableNo Debt/Eq0.00 EPS Q/Q78.50% Profit Margin- Rel Volume0.29 Prev Close0.87
ShortableYes LT Debt/Eq0.06 Earnings- Payout- Avg Volume307.40K Price0.92
Recom3.00 SMA2011.41% SMA5014.73% SMA200-17.43% Volume88,072 Change4.93%
Feb-25-19Upgrade Stifel Hold → Buy $2.50 → $3
Aug-03-18Reiterated Stifel Hold $3 → $2
Aug-13-20 07:00AM  
Jul-30-20 06:38AM  
Jun-19-20 06:15AM  
May-11-20 08:30AM  
May-08-20 08:00AM  
Apr-28-20 09:00AM  
Mar-25-20 08:44AM  
Mar-18-20 07:36AM  
Mar-17-20 05:21PM  
Mar-12-20 01:48PM  
Feb-27-20 07:31AM  
Feb-20-20 08:15AM  
Feb-13-20 09:00AM  
Feb-07-20 04:15PM  
Jan-24-20 11:30AM  
Jan-13-20 01:27PM  
Dec-18-19 08:30AM  
Dec-10-19 01:27PM  
Nov-27-19 12:10AM  
Nov-14-19 09:00AM  
Nov-13-19 09:43AM  
Nov-08-19 08:25AM  
Nov-05-19 05:15AM  
Nov-01-19 10:30AM  
Oct-31-19 07:15AM  
Oct-25-19 10:30AM  
Oct-24-19 08:15AM  
Oct-22-19 08:15AM  
Oct-04-19 12:48PM  
Oct-03-19 10:10AM  
Sep-28-19 12:42PM  
Sep-03-19 09:00AM  
Aug-05-19 09:00AM  
Aug-02-19 08:48AM  
Jul-26-19 04:00PM  
Jul-24-19 09:05AM  
Jul-23-19 08:30AM  
Jul-22-19 09:00AM  
Jul-16-19 08:30AM  
Jul-10-19 08:30AM  
Jun-24-19 08:30AM  
Jun-10-19 08:30AM  
Jun-04-19 11:42AM  
Jun-03-19 08:57AM  
May-24-19 05:50PM  
May-23-19 10:00AM  
May-21-19 04:01PM  
May-17-19 05:50PM  
May-02-19 10:33AM  
Apr-11-19 08:00AM  
Apr-03-19 08:30AM  
Mar-14-19 09:00AM  
Feb-27-19 09:00AM  
Feb-26-19 02:15AM  
Feb-22-19 10:05AM  
Feb-21-19 09:38AM  
Feb-15-19 09:00AM  
Jan-03-19 08:15AM  
Jan-02-19 09:00AM  
Dec-28-18 10:16AM  
Dec-27-18 05:53PM  
Dec-21-18 10:45AM  
Dec-20-18 11:07AM  
Dec-19-18 12:38PM  
Dec-13-18 09:21AM  
Nov-15-18 09:15AM  
Nov-13-18 08:40AM  
Nov-12-18 03:26PM  
Nov-07-18 09:15AM  
Nov-06-18 09:15AM  
Nov-02-18 09:25AM  
Oct-29-18 11:07AM  
Oct-26-18 10:30AM  
Oct-23-18 09:04AM  
Oct-09-18 09:02AM  
Sep-26-18 09:02AM  
Sep-12-18 02:00PM  
Aug-29-18 09:01AM  
Aug-27-18 09:02AM  
Aug-24-18 08:00AM  
Aug-23-18 12:50PM  
Aug-07-18 09:02AM  
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Plovanic William J.President & CEONov 12Buy1.6665,000107,822106,806Nov 14 08:30 AM